Skip to main content
SpringerLink
Log in

Early prediction of a long-term outcome by neutrophil-FISH in patients with CML receiving imatinib mesylate

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol. 2009;27(35):6041–51.

    Article  CAS  PubMed  Google Scholar 

  2. Baccarani M, Saglio G, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, et al. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2006;108(6):1809–20.

    Article  CAS  PubMed  Google Scholar 

  3. de Lavallade H, Apperley JF, Khorashad JS, Milojkovic D, Reid AG, Bua M, et al. Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis. J Clin Oncol. 2008;26(20):3358–63.

    Article  PubMed  Google Scholar 

  4. Hochhaus A, O’Brien SG, Guilhot F, Druker BJ, Branford S, Foroni L, et al. Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia. 2009;23(6):1054–61.

    Article  CAS  PubMed  Google Scholar 

  5. Kantarjian H, O’Brien S, Shan J, Huang X, Garcia-Manero G, Faderl S, et al. Cytogenetic and molecular responses and outcome in chronic myelogenous leukemia: need for new response definitions? Cancer. 2008;112(4):837–45.

    Article  PubMed  Google Scholar 

  6. Takahashi N, Miura I, Kobayashi Y, Kume M, Yoshioka T, Otane W, et al. Fluorescence in situ hybridization monitoring of BCR-ABL-positive neutrophils in chronic-phase chronic myeloid leukemia patients during the primary stage of imatinib mesylate therapy. Int J Hematol. 2005;81(3):235–41.

    Article  CAS  PubMed  Google Scholar 

  7. Takahashi N, Miura I, Saitoh K, Miura AB. Lineage involvement of stem cells bearing the Philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization. Blood. 1998;92(12):4758–63.

    CAS  PubMed  Google Scholar 

  8. Yagasaki F, Niwa T, Abe A, Ishikawa M, Kato C, Ogura K, et al. Correlation of quantification of major bcr-abl mRNA between TMA (transcription mediated amplification) method and real-time quantitative PCR. Rinsho Ketsueki. 2009;50(6):481–7. (Japanese)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Nephrology, and Rheumatology, Akita University, Hondo 1-1-1, Akita, Akita, 010-8543, Japan

    Naoto Takahashi, Yoshihiro Kameoka, Hiroyuki Tagawa, Hirobumi Saitoh, Tomoko Yoshioka, Naohito Fujishima, Makoto Hirokawa & Kenichi Sawada

  2. Department of Internal Medicine, Akita Kumiai General Hospital, Iijima-Nishifukuro 1-1-1, Akita, Akita, 011-0948, Japan

    Atsushi Kitabayashi

  3. Department of Internal Medicine, Tsuchizaki Hospital, Tsuchizakiminato-chuo 4-4-26, Akita, Akita, 011-0946, Japan

    Kaoru Takahashi

Authors
  1. Naoto Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshihiro Kameoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroyuki Tagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hirobumi Saitoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tomoko Yoshioka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Naohito Fujishima
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Atsushi Kitabayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kaoru Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Makoto Hirokawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kenichi Sawada
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naoto Takahashi.

About this article

Cite this article

Takahashi, N., Kameoka, Y., Tagawa, H. et al. Early prediction of a long-term outcome by neutrophil-FISH in patients with CML receiving imatinib mesylate. Int J Hematol 92, 559–561 (2010). https://doi.org/10.1007/s12185-010-0679-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-010-0679-5

Keywords

Search

Navigation